HWAM
TPTX

Hennion & Walsh Asset Management’s Turning Point Therapeutics, Inc. Common Stock TPTX Stock Holding History

Hennion & Walsh Asset Management’s Portfolio TPTX Stock Details TPTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-14,496
Closed -$1.09M – 809
2022
Q2 		$1.09M Buy
+14,496
New +$644K 0.07% 297

Hennion & Walsh Asset Management's TPTX Position: Q3 2022 in Review

Hennion & Walsh Asset Management sold out of Turning Point Therapeutics, Inc. Common Stock (TPTX) in Q3 2022, closing a stake of 14,496 shares — an estimated $1.09M sold.

Hennion & Walsh Asset Management first reported a position in TPTX in Q2 2022 and held it in 1 quarter. The position peaked at $1.09M in Q2 2022. 0 funds tracked by Wall St. Rank hold TPTX as of Q3 2022.

  • Hennion & Walsh Asset Management reported no remaining Turning Point Therapeutics, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Hennion & Walsh Asset Management sold 14,496 Turning Point Therapeutics, Inc. Common Stock shares in Q3 2022, an estimated $1.09M.
  • Hennion & Walsh Asset Management first reported a position in Turning Point Therapeutics, Inc. Common Stock in Q2 2022 and held it in 1 quarter.
  • Hennion & Walsh Asset Management's Turning Point Therapeutics, Inc. Common Stock position peaked at $1.09M in Q2 2022.
  • 0 funds tracked by Wall St. Rank held Turning Point Therapeutics, Inc. Common Stock as of Q3 2022.

Based on Hennion & Walsh Asset Management's 13F filing for Q3 2022, filed 14 Nov 2022.